Understanding how some bacteria resist treatment with cefiderocol
Mechanisms of cefiderocol nonsusceptibility and resistance evolution in carbapenem-resistant pathogens
This study is looking into why some tough bacteria, like Acinetobacter and Enterobacterales, don't respond to a new antibiotic called cefiderocol, so we can find better ways to treat infections caused by these germs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Arkansas for Med Scis NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project ID | NIH-10803156 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind antibiotic resistance in certain bacteria, specifically focusing on carbapenem-resistant Acinetobacter and Enterobacterales. It aims to understand why some strains of these bacteria are not susceptible to cefiderocol, a newer antibiotic approved for treating such infections. By examining genetic factors and the phenomenon of heteroresistance, the study seeks to uncover why some bacteria can survive treatment, which could lead to improved strategies for managing these difficult infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with infections caused by carbapenem-resistant Acinetobacter or Enterobacterales.
Not a fit: Patients with infections caused by bacteria that are not carbapenem-resistant may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better treatment options for patients suffering from infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Previous research has shown success in understanding antibiotic resistance mechanisms in other bacterial species, suggesting that this approach could yield valuable insights.
Where this research is happening
Little Rock, United States
- Univ of Arkansas for Med Scis — Little Rock, United States (Active)
Researchers
- Principal investigator: Huang, En — Univ of Arkansas for Med Scis
- Study coordinator: Huang, En
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.